Champions Oncology(CSBR),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

CSBR Champions Oncology

Trading 10-27 09:53:03 EDT

4.86

+0.00

0.00%

High4.86	Low4.86	Vol98.00
Open4.86	D1 Closing4.86	Amplitude0.00%
Mkt Cap67.49M	Tradable Cap29.35M	Total Shares13.89M
T/O479.58	T/O Rate0.00%	Tradable Shares6.04M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"CSBR","market":"US","secType":"STK","nameCN":"Champions Oncology","latestPrice":4.86,"timestamp":1793108789957,"preClose":4.86,"halted":0,"volume":98,"delay":0,"changeRate":0,"floatShares":6038500,"shares":13886326,"eps":-0.081892,"marketStatus":"Trading","change":0,"latestTime":"10-27 09:53:03 EDT","open":4.86,"high":4.86,"low":4.86,"amount":479.58005199999997,"amplitude":0,"askPrice":5.02,"askSize":100,"bidPrice":4.65,"bidSize":111,"shortable":3,"etf":0,"ttmEps":-0.081892,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1793131200000},"marketStatusCode":2,"adr":0,"adrRate":0,"exchange":"NASDAQ","adjPreClose":4.86,"postHourTrading":{"tag":"盘后","latestPrice":4.86,"preClose":4.86,"latestTime":"19:30 EDT","volume":4,"amount":19.4,"timestamp":1793057403738,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.20424,"impliedVol":1.4725,"impliedVolPercentile":0.498},"requestUrl":"/m/hq/s/CSBR/wiki","defaultTab":"wiki","newsList":[{"id":"2676516719","title":"Champions Oncology Stockholders Approve Governance and Incentive Plan","url":"https://stock-news.laohu8.com/highlight/detail?id=2676516719","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2676516719?lang=en_us&edition=fundamental","pubTime":"2026-10-17 01:42","pubTimestamp":1792172558,"startTime":"0","endTime":"0","summary":"Champions Oncology ( ($CSBR) ) has provided an update. On October 14, 2026, Champions Oncology, Inc. held its Annual Meeting of Stockholders, where...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/champions-oncology-stockholders-approve-governance-and-incentive-plan?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/champions-oncology-stockholders-approve-governance-and-incentive-plan?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4121","CSBR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2676515640","title":"Champions Oncology Holds Annual Stockholder Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2676515640","media":"Reuters","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2676515640?lang=en_us&edition=fundamental","pubTime":"2026-10-17 00:15","pubTimestamp":1792167355,"startTime":"0","endTime":"0","summary":"Champions Oncology Holds Annual Stockholder MeetingChampions Oncology shareholders approved the 2026 Equity Incentive Plan at the annual meeting on October 14, 2026.Stockholders ratified EisnerAmper L","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261016:nNDL3jQ1S0:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CSBR","BK4121"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666570378","title":"Champions Oncology Earnings Call Highlights Margin Momentum","url":"https://stock-news.laohu8.com/highlight/detail?id=2666570378","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666570378?lang=en_us&edition=fundamental","pubTime":"2026-09-12 08:12","pubTimestamp":1789171943,"startTime":"0","endTime":"0","summary":"Champions Oncology (($CSBR)) has held its Q1 earnings call. Read on for the main highlights of the call. Champions Oncology’s latest earnings call ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/champions-oncology-earnings-call-highlights-margin-momentum?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/champions-oncology-earnings-call-highlights-margin-momentum?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["CSBR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666519877","title":"Champions Oncology (CSBR) Q1 Fiscal 2027 Earnings Call: Revenue Up 9%, Services Margin Reaches 51%","url":"https://stock-news.laohu8.com/highlight/detail?id=2666519877","media":"TradingKey","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666519877?lang=en_us&edition=fundamental","pubTime":"2026-09-11 05:40","pubTimestamp":1789076425,"startTime":"0","endTime":"0","summary":"Champions Oncology Q1 fiscal 2027 revenue rose 9% to $15.2 million, adjusted EBITDA reached $671,000 and oncology services margin improved to 51%.","market":"sh","thumbnail":"https://resource.tradingkey.com/cdn/images/article/news/stock13.jpg","type":0,"news_type":0,"thumbnails":["https://resource.tradingkey.com/cdn/images/article/news/stock13.jpg"],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tradingkey.com/news/transcripts/262161886-tradingkey","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CSBR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666449515","title":"Champions Oncology Q1 Adj. EPS $0.05 Up From $0.01 YoY, Sales $15.232M Up From $13.995M YoY","url":"https://stock-news.laohu8.com/highlight/detail?id=2666449515","media":"Benzinga Earnings","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666449515?lang=en_us&edition=fundamental","pubTime":"2026-09-11 04:26","pubTimestamp":1789071975,"startTime":"0","endTime":"0","summary":"Champions Oncology (NASDAQ:CSBR) reported quarterly earnings of $0.05 per share. This is a 400 percent increase over earnings of $0.01 per share from the same period last year.  The company reported $15.232 million in","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/26/09/61728021/champions-oncology-q1-adj-eps-0-05-0-01-yoy-sales-15-232m-13-995m-yoy","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Champions Oncology Q1 Adj. EPS $0.05 Up From $0.01 YoY, Sales $15.232M Up From $13.995M YoY","news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CSBR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666513067","title":"Champions Oncology Q1 Revenue Rises on Research Services Business","url":"https://stock-news.laohu8.com/highlight/detail?id=2666513067","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666513067?lang=en_us&edition=fundamental","pubTime":"2026-09-11 04:10","pubTimestamp":1789071012,"startTime":"0","endTime":"0","summary":"Champions Oncology Q1 revenue rises on research services businessOverviewUS translational oncology research firm's fiscal Q1 revenue grew 8.8% yr/yrOncology services margin improved to 51% from 43% in","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260910:nL1N45210N:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0203345920.USD","LU2357627491.SGD","LU1585245621.USD","LU1355424745.HKD","LU0949170426.SGD","BIB","LU0267386448.USD","LU0827474353.SGD","LU2539964713.USD","IBBQ","LU0211326839.USD","BMY","AZN.UK","LU1093756168.USD","LU0321505439.SGD","AMGN","LU1430594728.SGD","LU0640478417.SGD","03165","LU1078025761.USD","PJP","LU1153584641.USD","LU1883839398.USD","LU1267930573.SGD","TBXU","LU0096364046.USD","PBE","LU1196032939.SGD","LU0868494617.USD","LU1273509221.SGD","FTXH","LU0823416689.USD","LU1119994496.HKD","LU0784384876.USD","LU2360032135.SGD","LU1814569148.SGD","LU1868836757.USD","BBH","LU0211327993.USD","LU2293690082.USD","IHE","LU1084165304.USD","LU0171276677.USD","LU1323610961.USD","IBB","LU1074936037.SGD","CSBR","LU3187612489.SGD","LU0211328371.USD","LU1261432733.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666131575","title":"Champions Oncology Q1 Adjusted EPS USD 0.05","url":"https://stock-news.laohu8.com/highlight/detail?id=2666131575","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666131575?lang=en_us&edition=fundamental","pubTime":"2026-09-11 04:01","pubTimestamp":1789070464,"startTime":"0","endTime":"0","summary":"BRIEF-Champions Oncology Q1 Adjusted EPS USD 0.05Sep 10 (Reuters) - Champions Oncology Q1 revenue USD 15.2 million.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260910:nPLXRST4F7:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4121","CSBR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666513919","title":"Champions Oncology Q1 FY27 Adjusted Ebitda More than Doubled to $671,000; Revenue Rises 8.8% to $15.2 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2666513919","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666513919?lang=en_us&edition=fundamental","pubTime":"2026-09-11 04:00","pubTimestamp":1789070448,"startTime":"0","endTime":"0","summary":"Champions Oncology Q1 FY27 adjusted EBITDA more than doubled to $671,000; revenue rises 8.8% to $15.2 millionChampions Oncology posted revenue of USD 15.2 million, up 8.8% year over year, for fiscal Q","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260910:nNDL8746Cb:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4121","CSBR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666513957","title":"Champions Oncology Q1 Revenue USD 15.2 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2666513957","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666513957?lang=en_us&edition=fundamental","pubTime":"2026-09-11 04:00","pubTimestamp":1789070404,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260910:nPLXRST4F7:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["CSBR","BK4121"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664135831","title":"Champions Oncology to Report Q1 Results After Market Close, Host Conference Call","url":"https://stock-news.laohu8.com/highlight/detail?id=2664135831","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664135831?lang=en_us&edition=fundamental","pubTime":"2026-09-04 23:15","pubTimestamp":1788534918,"startTime":"0","endTime":"0","summary":"Champions Oncology to report Q1 results after market close, host conference callChampions Oncology schedules first-quarter results for the period ended July 31, 2026, on Sept. 10, 2026.Conference call","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260904:nNDL8dc2gn:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4121","CSBR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664854174","title":"Champions Oncology expands integrated radiopharmaceutical development platform","url":"https://stock-news.laohu8.com/highlight/detail?id=2664854174","media":"TIPRANKS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664854174?lang=en_us&edition=fundamental","pubTime":"2026-09-01 21:20","pubTimestamp":1788268854,"startTime":"0","endTime":"0","summary":"Champions Oncology (CSBR) announced the expansion of its integrated radiopharmaceutical development platform with new in-house SPECT/CT imaging cap...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/champions-oncology-expands-integrated-radiopharmaceutical-development-platform-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/champions-oncology-expands-integrated-radiopharmaceutical-development-platform-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4121","CSBR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664685149","title":"Champions Oncology Adds In-House Spect/ct Imaging to Radiopharmaceutical Development Platform","url":"https://stock-news.laohu8.com/highlight/detail?id=2664685149","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664685149?lang=en_us&edition=fundamental","pubTime":"2026-09-01 21:05","pubTimestamp":1788267903,"startTime":"0","endTime":"0","summary":"Champions Oncology adds in-house SPECT/CT imaging to radiopharmaceutical development platformChampions Oncology expanded its radiopharmaceutical development platform with in-house SPECT/CT imaging to ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260901:nNDL8qkM9L:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CSBR","BK4121"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663346013","title":"Champions Oncology Announces Annual Shareholder Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2663346013","media":"Reuters","labels":["conferences","event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663346013?lang=en_us&edition=fundamental","pubTime":"2026-08-29 03:37","pubTimestamp":1787945842,"startTime":"0","endTime":"0","summary":"Champions Oncology announces annual shareholder meetingChampions Oncology shareholders meet in Hackensack, New Jersey on Oct. 14, 2026.Vote on electing seven directors for the coming year.Ballot inclu","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260828:nNDL4d3xp6:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences,event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4121","CSBR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659788179","title":"Champions Oncology Earnings Call Highlights Growth, Risks","url":"https://stock-news.laohu8.com/highlight/detail?id=2659788179","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659788179?lang=en_us&edition=fundamental","pubTime":"2026-08-16 08:27","pubTimestamp":1786840035,"startTime":"0","endTime":"0","summary":"Champions Oncology (($CSBR)) has held its Q4 earnings call. Read on for the main highlights of the call. Champions Oncology’s latest earnings call ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/champions-oncology-earnings-call-highlights-growth-risks?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/champions-oncology-earnings-call-highlights-growth-risks?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["CSBR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655838157","title":"Waste Management Q2 Revenue Rises Driven by Core Price Increases","url":"https://stock-news.laohu8.com/highlight/detail?id=2655838157","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655838157?lang=en_us&edition=fundamental","pubTime":"2026-07-29 04:40","pubTimestamp":1785271247,"startTime":"0","endTime":"0","summary":"Waste Management Q2 revenue rises driven by core price increasesOverviewUS waste services provider's Q2 revenue rose 4% but slightly missed analyst expectationsAdjusted EPS for Q2 beat analyst expecta","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260728:nL1N43U1BH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0094547139.USD","LU2413666426.HKD","LU2413666699.HKD","BK4121","LU1585245621.USD","LU0158827948.USD","LU2362541273.HKD","BK4120","IDU","BK4566","LU2362541513.USD","LU0689626769.HKD","LU1892829315.USD","LU1923621640.USD","LU0057025933.USD","LU1803068623.USD","LU1989772923.USD","LU2125910179.SGD","LU2271345857.HKD","CSBR","LU1721428933.USD","LU2023251221.USD","LU1623119135.USD","LU2463526074.USD","LU2125910336.SGD","LU0069063385.USD","WM","LU1939255532.USD","LU2089279066.USD","LU2028103732.USD","BK4588","LU2211814178.USD","LU2023250504.SGD","LU2089283258.USD","BK4533","LU2111349929.HKD","LU2240825500.USD","LU0289960550.SGD","LU0511384066.AUD","LU2238339852.HKD","LU2023250843.SGD","LU2355687059.USD","LU0175139822.USD","LU2298064838.USD","LU2089284900.SGD","LU0124676726.USD","LU0347712357.USD","LU0289739343.SGD","BK4585","EVX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654702338","title":"Champions Oncology reports Q4 adjusted EPS 1c vs. (8c) last year","url":"https://stock-news.laohu8.com/highlight/detail?id=2654702338","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2654702338?lang=en_us&edition=fundamental","pubTime":"2026-07-28 04:40","pubTimestamp":1785184820,"startTime":"0","endTime":"0","summary":"Reports Q4 revenue $13.8M vs. $12.4M last year. The company noted that a reduction in the cost of oncology revenue reflected continued cost discipl...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/champions-oncology-reports-q4-adjusted-eps-1c-vs-8c-last-year-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/champions-oncology-reports-q4-adjusted-eps-1c-vs-8c-last-year-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["CSBR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654804022","title":"Champions Oncology Q4 Adj. EPS $0.01 Beats $(0.05) Estimate, Sales $13.835M Beat $12.886M Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2654804022","media":"Benzinga Earnings","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2654804022?lang=en_us&edition=fundamental","pubTime":"2026-07-28 04:07","pubTimestamp":1785182833,"startTime":"0","endTime":"0","summary":"Champions Oncology (NASDAQ:CSBR) reported quarterly earnings of $0.01 per share which beat the analyst consensus estimate of $(0.05) by 120 percent. This is a 114.29 percent increase over losses of $(0.07) per share","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/26/07/60710545/champions-oncology-q4-adj-eps-0-01-beats-0-05-estimate-sales-13-835m-beat-12-886m-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Champions Oncology Q4 Adj. EPS $0.01 Beats $(0.05) Estimate, Sales $13.835M Beat $12.886M Estimate","news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CSBR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654927040","title":"Champions Oncology Q4 Adjusted EPS USD 0.01","url":"https://stock-news.laohu8.com/highlight/detail?id=2654927040","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2654927040?lang=en_us&edition=fundamental","pubTime":"2026-07-28 04:01","pubTimestamp":1785182461,"startTime":"0","endTime":"0","summary":"BRIEF-Champions Oncology Q4 Adjusted EPS USD 0.01Jul 27 (Reuters) - Champions Oncology Q4 EPS USD -0.05.Q4 revenue USD 13.8 million","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260727:nPLXPZSXKZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CSBR","BK4121"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654409240","title":"Champions Oncology Q4 Adjusted Ebitda Swings to Profit of $158,000; Revenue Rises 12% to $13.8 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2654409240","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2654409240?lang=en_us&edition=fundamental","pubTime":"2026-07-28 04:01","pubTimestamp":1785182460,"startTime":"0","endTime":"0","summary":"Champions Oncology Q4 adjusted EBITDA swings to profit of $158,000; revenue rises 12% to $13.8 millionChampions Oncology posted Q4 revenue of $13.8 million, up 12% from a year earlier, as GAAP net los","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260727:nNDL75lrfC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4121","CSBR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654991040","title":"Champions Oncology Q4 EPS USD -0.05","url":"https://stock-news.laohu8.com/highlight/detail?id=2654991040","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2654991040?lang=en_us&edition=fundamental","pubTime":"2026-07-28 04:00","pubTimestamp":1785182401,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260727:nPLXPZSXKZ:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["CSBR","BK4121"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.championsoncology.com","stockEarnings":[{"period":"1week","weight":0.0362},{"period":"1month","weight":-0.0082},{"period":"3month","weight":-0.1212},{"period":"6month","weight":-0.1692},{"period":"1year","weight":-0.2946},{"period":"ytd","weight":-0.2967}],"compareEarnings":[{"period":"1week","weight":-0.0014},{"period":"1month","weight":-0.0078},{"period":"3month","weight":0.0331},{"period":"6month","weight":0.0756},{"period":"1year","weight":0.1301},{"period":"ytd","weight":0.1224}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Champions Oncology, Inc., a technology-enabled research company, provides transformative technology solutions for drug discovery and development in the United States. The company, through its Tumorgraft Technology Platform, provides personalized cancer care based upon the implantation of human tumors in immune-deficient mice. It also offers Translational Oncology Solutions that utilizes its technology platform to assist pharmaceutical and biotechnology companies with their drug development process. In addition, it offers Lumin Bioinformatics, an oncology data-driven software program which contains comprehensive information derived from research services and clinical studies. The company markets its products through internet, word of mouth, and sales force to pharmaceutical and biotechnology companies. Champions Oncology, Inc. was formerly known as Champions Biotechnology, Inc. and changed its name to Champions Oncology, Inc. in April 2011. The company was incorporated in 1985 and is headquartered in Hackensack, New Jersey.","yearOnYearQuotes":[{"month":1,"riseRate":0.421053,"avgChangeRate":0.083367},{"month":2,"riseRate":0.578947,"avgChangeRate":0.005577},{"month":3,"riseRate":0.35,"avgChangeRate":0.015257},{"month":4,"riseRate":0.4,"avgChangeRate":-0.018269},{"month":5,"riseRate":0.45,"avgChangeRate":0.049247},{"month":6,"riseRate":0.5,"avgChangeRate":0.049593},{"month":7,"riseRate":0.35,"avgChangeRate":-0.038695},{"month":8,"riseRate":0.35,"avgChangeRate":-0.013059},{"month":9,"riseRate":0.6,"avgChangeRate":0.089195},{"month":10,"riseRate":0.3,"avgChangeRate":0.013635},{"month":11,"riseRate":0.368421,"avgChangeRate":-0.003679},{"month":12,"riseRate":0.578947,"avgChangeRate":0.128252}],"exchange":"NASDAQ","name":"Champions Oncology","nameEN":"Champions Oncology"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.52.0","shortVersion":"4.52.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Champions Oncology(CSBR),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Champions Oncology(CSBR) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Champions Oncology,CSBR,Champions Oncology股票,Champions Oncology股票老虎,Champions Oncology股票老虎国际,Champions Oncology行情,Champions Oncology股票行情,Champions Oncology股价,Champions Oncology股市,Champions Oncology股票价格,Champions Oncology股票交易,Champions Oncology股票购买,Champions Oncology股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Champions Oncology(CSBR),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Champions Oncology(CSBR) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}